130 related articles for article (PubMed ID: 30867792)
1. Decorin as a prognostic biomarker in patients with malignant peripheral nerve sheath tumors.
Jia X; Chen C; Chen L; Yu C; Kondo T
Oncol Lett; 2019 Mar; 17(3):3517-3522. PubMed ID: 30867792
[TBL] [Abstract][Full Text] [Related]
2. The role of phosphorylated signal transducer and activator of transcription 3 (pSTAT3) in peripheral nerve sheath tumours.
Panse G; Leung CH; Ingram DR; Wani K; Torres KE; Lin H; Lazar AJ; Wang WL
Histopathology; 2017 May; 70(6):946-953. PubMed ID: 27992966
[TBL] [Abstract][Full Text] [Related]
3. Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors.
Matsumine A; Shintani K; Kusuzaki K; Matsubara T; Satonaka H; Wakabayashi T; Iino T; Uchida A
J Surg Oncol; 2007 Oct; 96(5):411-8. PubMed ID: 17579351
[TBL] [Abstract][Full Text] [Related]
4. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of Head and Neck and Non-Head and Neck Malignant Peripheral Nerve Sheath Tumors.
Patel TD; Shaigany K; Fang CH; Park RC; Baredes S; Eloy JA
Otolaryngol Head Neck Surg; 2016 Jan; 154(1):113-20. PubMed ID: 26408559
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of H3K27 trimethylation in malignant peripheral nerve sheath tumors.
Otsuka H; Kohashi K; Yoshimoto M; Ishihara S; Toda Y; Yamada Y; Yamamoto H; Nakashima Y; Oda Y
Pathol Res Pract; 2018 Mar; 214(3):417-425. PubMed ID: 29482987
[TBL] [Abstract][Full Text] [Related]
7. The effects of tumor location on diagnostic criteria for canine malignant peripheral nerve sheath tumors (MPNSTs) and the markers for distinction between canine MPNSTs and canine perivascular wall tumors.
Suzuki S; Uchida K; Nakayama H
Vet Pathol; 2014 Jul; 51(4):722-36. PubMed ID: 24009270
[TBL] [Abstract][Full Text] [Related]
8. Superficial or cutaneous malignant peripheral nerve sheath tumor--clinical experience at Taipei Veterans General Hospital.
Feng CJ; Ma H; Liao WC
Ann Plast Surg; 2015 May; 74 Suppl 2():S85-8. PubMed ID: 25695445
[TBL] [Abstract][Full Text] [Related]
9. Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor.
Zhou W; Du X; Song F; Zheng H; Chen K; Zhang W; Yang J
Oncotarget; 2016 Apr; 7(16):22234-44. PubMed ID: 26993773
[TBL] [Abstract][Full Text] [Related]
10. p53 and Ki-67 proliferating cell nuclear antigen in benign and malignant peripheral nerve sheath tumors in children.
Liapis H; Marley EF; Lin Y; Dehner LP
Pediatr Dev Pathol; 1999; 2(4):377-84. PubMed ID: 10347283
[TBL] [Abstract][Full Text] [Related]
11. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
[TBL] [Abstract][Full Text] [Related]
12. [A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)].
Malerba M; Garofalo A
Tumori; 2003; 89(4 Suppl):246-50. PubMed ID: 12903608
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Immunohistochemical Markers and Genetic Alterations in Malignant Peripheral Nerve Sheath Tumors: A Systematic Review.
Martin E; Acem I; Grünhagen DJ; Bovée JVMG; Verhoef C
Front Oncol; 2020; 10():594069. PubMed ID: 33415076
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of malignant peripheral nerve sheath tumors.
Gachiani J; Kim D; Nelson A; Kline D
Neurosurg Focus; 2007 Jun; 22(6):E13. PubMed ID: 17613204
[TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
16. Malignant peripheral nerve sheath tumors in Africa: a clinicopathological study.
Nthumba PM; Juma PI
ISRN Surg; 2011; 2011():526454. PubMed ID: 22084762
[TBL] [Abstract][Full Text] [Related]
17. Malignant peripheral nerve sheath tumors of the trigeminal nerve: a systematic review of 36 cases.
Schmidt RF; Yick F; Boghani Z; Eloy JA; Liu JK
Neurosurg Focus; 2013 Mar; 34(3):E5. PubMed ID: 23451818
[TBL] [Abstract][Full Text] [Related]
18. Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions.
Zhou H; Coffin CM; Perkins SL; Tripp SR; Liew M; Viskochil DH
Am J Surg Pathol; 2003 Oct; 27(10):1337-45. PubMed ID: 14508395
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis-associated malignant peripheral nerve sheath tumors in children have a worse prognosis: A nationwide cohort study.
Martin E; Coert JH; Flucke UE; Slooff WM; van de Sande MAJ; van Noesel MM; Grünhagen DJ; Wijnen MHWA; Verhoef C
Pediatr Blood Cancer; 2020 Apr; 67(4):e28138. PubMed ID: 31889416
[TBL] [Abstract][Full Text] [Related]
20. A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors.
Owosho AA; Estilo CL; Huryn JM; Chi P; Antonescu CR
Head Neck Pathol; 2018 Jun; 12(2):151-159. PubMed ID: 28762137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
